High serum adenosine deaminase activity and its correlation with lymphocyte subsets in myasthenia gravis
- PMID: 2089134
- DOI: 10.1016/0022-510x(90)90030-q
High serum adenosine deaminase activity and its correlation with lymphocyte subsets in myasthenia gravis
Abstract
Serum adenosine deaminase (ADA) activity and peripheral lymphocyte subsets of patients with myasthenia gravis (MG) were simultaneously measured. The ADA activity in MG (n = 30) was significantly higher as compared with normal control (n = 150) and multiple sclerosis (n = 12) (P less than 0.05). The ADA activity of generalized MG was higher than that of ocular MG, while a significant elevation of ADA activity was observed in grade IIB as compared with grade I of Osserman's classification (P less than 0.05). A trend of high ADA activity was demonstrated in those whose disease had advanced to a severe degree associated with unstable clinical features (P less than 0.05). In addition, there was a significant elevation of ADA activity in patients who disclosed positive anti-Ach-receptor-antibody as compared with negative one (P less than 0.05). There was no specific trend among the proportions of the subsets of peripheral lymphocytes which could reflect the severity of MG, however, the proportion of OK Ia1+ tended to be higher with advancing the grade of MG. Interestingly enough, a close correlation was found between the ADA activity and the proportion of OK Ia1+ cells (P less than 0.05). From the above results, it was concluded that high ADA may be responsible for the pathophysiology of MG through the alteration of peripheral lymphocyte function.
Similar articles
-
An ocular form of myasthenia gravis with a high titer of anti-MuSK antibodies during a long-term follow-up.Intern Med. 2012;51(21):3077-9. doi: 10.2169/internalmedicine.51.8196. Epub 2012 Nov 1. Intern Med. 2012. PMID: 23124154 Review.
-
Relationship between anti-acetylcholine receptor antibody titres and severity of myasthenia gravis.J Pak Med Assoc. 2009 May;59(5):289-92. J Pak Med Assoc. 2009. PMID: 19438131
-
Autoimmune myasthenia gravis in childhood.Semin Neurol. 2004 Mar;24(1):101-10. doi: 10.1055/s-2004-829591. Semin Neurol. 2004. PMID: 15229797 Review.
-
A correlation study between serum adenosine deaminase activities and peripheral lymphocyte subsets in Parkinson's disease.J Neurol Sci. 1995 Oct;132(2):170-3. doi: 10.1016/0022-510x(95)00136-p. J Neurol Sci. 1995. PMID: 8543943 Clinical Trial.
-
Isozyme analysis of the high serum adenosine deaminase activity in patients with myasthenia gravis.Intern Med. 1995 Feb;34(2):81-4. doi: 10.2169/internalmedicine.34.81. Intern Med. 1995. PMID: 7727883
Cited by
-
The Purinergic System as a Pharmacological Target for the Treatment of Immune-Mediated Inflammatory Diseases.Pharmacol Rev. 2019 Jul;71(3):345-382. doi: 10.1124/pr.117.014878. Pharmacol Rev. 2019. PMID: 31235653 Free PMC article. Review.
-
The role of adenosinergic pathway in human autoimmune diseases.Immunol Res. 2016 Dec;64(5-6):1133-1141. doi: 10.1007/s12026-016-8870-2. Immunol Res. 2016. PMID: 27665459 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials